• Cryptocurrencies
  • Prediction Markets
  • News
  • Agentic Trading
  • Blog
  • Leagues

Search Cryptocurrencies

Trending Cryptocurrencies

CoinRithm

Company

Legal Entity
Bees-x Limited
Company Number
13308136
Incorporated In
England and Wales
Registered Office
Monmouth House, High Street, Watford, England, WD17 1LN

CoinRithm is an information and research service operated by Bees-x Limited. It is not authorised by the Financial Conduct Authority (FCA) to carry on regulated activities, and nothing on this site is financial advice.

Explore

CryptocurrenciesPrediction MarketsNewsBlogAgent ArenaLeagues

Features

DashboardMock TradeAgentic TradingPortfolioWatchlistSettings

Company

About UsMethodologyTerms of UsePrivacy PolicyCookie PolicyDisclaimer

Support

Contact SupportFAQDeveloper kitMCP docs

Socials

X (Twitter)FacebookLinkedInTelegramInstagramTikTokYouTube
© 2026 CoinRithm. All rights reserved.
Get it on Google PlayDownload on the App Store
  • Home
  • MarketsPrediction Markets
  • News
  • Dashboard
  1. Prediction Markets
  2. Health & Medicine
  3. When will Compass Pathways submit a NDA for COMP360 psilocybin?
When will Compass Pathways submit a NDA for COMP360 psilocybin?

When will Compass Pathways submit a NDA for COMP360 psilocybin?

1.0% (24h)Health & MedicineOne-OffScienceBusiness & Corporate2mo
KalshiKalshiCheck availabilityKYC required2% fee
Current implied probability
before September
before September 31%+1.0%
Leader of 6 outcomes
Market quality

28 / 100

Low quality
24h Volume

$0.3

Liquidity

$44.1

Low liquidity
Bid / Ask

22.0% / 31.0%

Spread

40.9%

Wide spread
Market data

Updated 2 minutes ago

Mar 24, 26, 2:00 PMSep 1, 26, 2:00 PM

Trends

Outcome24hChance

Selected outcome

before September31%

Rules

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.

Related Markets

When will Beam Therapeutics submit a BLA for Risto-cel?

When will Beam Therapeutics submit a BLA for Risto-cel?

$5.3
before April 2027: 72%KalshiKALSHI
Will there be a year without polio before 2030?

Will there be a year without polio before 2030?

$0
Yes: 10%KalshiKALSHI
When will Intellia Therapeutics submit a BLA for Lonvo-z?

When will Intellia Therapeutics submit a BLA for Lonvo-z?

$0
before September: 45%KalshiKALSHI
Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

$159.5
Uganda: 100%PolymarketPOLYMARKET
US fertility rate up in Q1 2026?

US fertility rate up in Q1 2026?

$0
Yes: 36%PolymarketPOLYMARKET
Which geographical areas will Tomorrow Bio cover at the end of 2026?

Which geographical areas will Tomorrow Bio cover at the end of 2026?

$1.2K
🇨🇦 Canada: 23.9%Manifold MarketsMANIFOLD MARKETS

Active in these topics

BitcoinBTC$62,795.58+1.86%EthereumETH$1,657.23+1.21%SolanaSOL$65.17+1.50%DogecoinDOGE$0.085+1.27%XRPXRP$1.12+0.41%BNBBNB$602.33+2.58%

Related News

JPMorgan plans longer-running AI agents for corporate workflows Crypto NewsA16z, Paradigm lead $175 million bet to move global credit markets onchainCoindeskMorpho raises $175M at $2B valuation for institutional DeFi pushCrypto NewsAmazon signs Corning fiber deal to expand U.S. data centersCrypto NewsSpaceX Price Prediction: Will IPO Hype Justify a Multi-Trillion Dollar Valuation?Blockchain ReporterA massive hiring wave reveals trading firms are no longer viewing Polymarket as a niche betting toolCoindesk

Rules

If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Sep 1, 2026, then the market resolves to Yes.

Kalshi
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Oct 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Nov 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Dec 1, 2026, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Jan 1, 2027, then the market resolves to Yes.
  • If COMPASS Pathways plc submits a NDA for COMP360 psilocybin to the FDA before Apr 1, 2027, then the market resolves to Yes.